Evolent Health Financial Statements (EVH)
|
|
|
|
Report date
|
|
|
09.05.2025 |
11.08.2025 |
07.11.2025 |
25.02.2026 |
07.05.2026 |
|
07.05.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
483.6 |
444.3 |
479.5 |
468.7 |
496.2 |
|
1 889 |
|
Operating Income, bln rub |
|
|
-1.62 |
-1.17 |
0.886 |
-9.64 |
-506.8 |
|
-516.8 |
|
EBITDA, bln rub |
? |
|
-28.7 |
12.8 |
14.5 |
-359.9 |
-21.0 |
|
-353.6 |
|
Net profit, bln rub |
? |
|
-64.6 |
-19.9 |
-20.9 |
-429.1 |
-26.6 |
|
-496.5 |
|
|
OCF, bln rub |
? |
|
4.57 |
-30.3 |
15.8 |
48.8 |
-0.984 |
|
33.3 |
|
CAPEX, bln rub |
? |
|
8.60 |
8.77 |
8.96 |
7.76 |
6.41 |
|
31.9 |
|
FCF, bln rub |
? |
|
-4.03 |
-39.1 |
6.85 |
41.0 |
-7.39 |
|
1.40 |
|
Dividend payout, bln rub
|
|
|
4.58 |
4.62 |
0.000 |
0.000 |
0.000 |
|
4.62 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
-0.93% |
|
|
OPEX, bln rub |
|
|
104.1 |
101.6 |
98.9 |
17.1 |
94.4 |
|
311.9 |
|
Cost of production, bln rub |
|
|
381.2 |
343.9 |
379.8 |
488.3 |
412.5 |
|
1 624 |
|
R&D, bln rub |
|
|
0.000 |
0.000 |
0.006 |
0.000 |
0.000 |
|
0.006 |
|
Interest expenses, bln rub |
|
|
10.4 |
11.6 |
16.5 |
19.0 |
16.9 |
|
64.0 |
|
|
Assets, bln rub |
|
|
2 653 |
2 462 |
2 453 |
1 899 |
1 879 |
|
1 879 |
|
Net Assets, bln rub |
? |
|
935.5 |
896.0 |
842.2 |
415.2 |
396.4 |
|
396.4 |
|
Debt, bln rub |
|
|
870.1 |
853.2 |
1 082 |
989.7 |
11.9 |
|
11.9 |
|
Cash, bln rub |
|
|
246.5 |
151.0 |
116.7 |
151.9 |
142.0 |
|
142.0 |
|
Net debt, bln rub |
|
|
623.6 |
702.2 |
965.7 |
837.8 |
-130.1 |
|
-130.1 |
|
|
Ordinary share price, rub |
|
|
9.47 |
11.3 |
8.46 |
4.00 |
2.28 |
|
4.18 |
|
Number of ordinary shares, mln |
|
|
115.3 |
115.9 |
114.1 |
114.2 |
111.9 |
|
111.9 |
|
|
Market cap, bln rub |
|
|
1 092 |
1 305 |
965 |
457 |
255 |
|
468 |
|
EV, bln rub |
? |
|
1 716 |
2 007 |
1 931 |
1 295 |
125 |
|
338 |
|
Book value, bln rub |
|
|
-870 |
-892 |
-995 |
-864 |
-868 |
|
-868 |
|
|
EPS, rub |
? |
|
-0.56 |
-0.17 |
-0.18 |
-3.76 |
-0.24 |
|
-4.44 |
|
FCF/share, rub |
|
|
-0.03 |
-0.34 |
0.06 |
0.36 |
-0.07 |
|
0.01 |
|
BV/share, rub |
|
|
-7.54 |
-7.70 |
-8.73 |
-7.57 |
-7.75 |
|
-7.75 |
|
|
EBITDA margin, % |
? |
|
-5.94% |
2.87% |
3.03% |
-76.8% |
-4.24% |
|
-18.7% |
|
Net margin, % |
? |
|
-13.4% |
-4.48% |
-4.35% |
-91.6% |
-5.37% |
|
-26.3% |
|
FCF yield, % |
? |
|
-0.89% |
-4.84% |
-7.12% |
1.04% |
0.55% |
|
0.30% |
|
ROE, % |
? |
|
-11.6% |
-14.6% |
-15.2% |
-128.7% |
-125.3% |
|
-125.3% |
|
ROA, % |
? |
|
-4.11% |
-5.30% |
-5.22% |
-28.1% |
-26.4% |
|
-26.4% |
|
|
P/E |
? |
|
-10.0 |
-10.0 |
-7.53 |
-0.85 |
-0.51 |
|
-0.94 |
|
P/FCF |
|
|
-112.3 |
-20.7 |
-14.1 |
96.1 |
182.9 |
|
335.3 |
|
P/S |
? |
|
0.46 |
0.59 |
0.47 |
0.24 |
0.14 |
|
0.25 |
|
P/BV |
? |
|
-1.26 |
-1.46 |
-0.97 |
-0.53 |
-0.29 |
|
-0.54 |
|
EV/EBITDA |
? |
|
52.2 |
215.6 |
162.4 |
-3.58 |
-0.35 |
|
-0.95 |
|
Debt/EBITDA |
|
|
19.0 |
75.4 |
81.3 |
-2.32 |
0.37 |
|
0.37 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
0.06% |
0.00% |
0.00% |
|
0.02% |
|
|
CAPEX/Revenue, % |
|
|
1.78% |
1.97% |
1.87% |
1.66% |
1.29% |
|
1.69% |
|
| Evolent Health shareholders |
